Through the eight authoritative examinations of the small molecule minimally invasive treatment system, the etiology and lesion site of every ankylosing spondylitis patient can be accurately determined; Then, the national patent "small molecule minimally invasive technology" is applied to minimally invasive intervention of bioactive peptides into the diseased joint cavity, releasing and separating adhesion tissues, effectively improving blood microcirculation, eliminating pathogenic inflammatory factors, eliminating chronic inflammation, making "nutrition come in, inflammatory factors come out", gradually alleviating the symptoms of edema and inflammatory erosion, and the active components of growth factors released by small molecular peptides stimulate joint synovium, tendons and ligaments, nerves and blood vessels to fully absorb nutrients, so as to carry out normal aging. Strengthen daily conditioning to prevent the recurrence of the disease.
Rheumatoid immune diseases such as ankylosing spondylitis and rheumatoid arthritis are similar to most clinical diseases, which often emphasize "seven-divided treatment and three-divided nutrition" and prevention is also very important. Therefore, in order to prevent the recurrence of ankylosing spondylitis after rehabilitation, the small molecule minimally invasive treatment system emphasizes the need to make a good diet, adhere to appropriate exercise and functional exercise, and maintain a good mentality and adequate sleep according to the regional differences and individual physical differences of patients.